265 Sheraton Blvd.
Macon, GA 31210
Tel: (478) 746-8626 ext 260
The purpose of this phase 3 study is to evaluate glycemic control in participants with T2DM who are taking mealtime study insulin LY900014 in combination with long-acting insulin glargine.
The purpose of this phase 3 study is to evaluate the safety and effects of study tirzepatide on body weight compared to placebo T2DM patients who are overweight or obese.
The purpose of the study is to evaluate the dose-response efficacy, safety, and pharmacokinetics (PK) of AZD5718 compared to placebo in participants with proteinuric chronic kidney disease (CKD).
Condition: Kidney Disease
This is a phase 2 study evaluating the efficacy and safety of a low and high dose of study LX9211 compared to placebo in patients with moderate to severe diabetic peripheral neuropathy.
Condition: Diabetic Peripheral Neuropathy
This study is being done to assess the efficacy and safety of tirzepatide compared to dulaglutide in patients with type 2 diabetes and increased cardiovascular risk.
A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease